Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia A, Haemophilia B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04768699
What this trial is testing

Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Early research (Phase 1)Study completedNCT00716716
What this trial is testing

Phase I/IIa Study of FIXFc in Hemophilia B Patients

Who this might be right for
Hemophilia B
Bioverativ Therapeutics Inc. 10
Large-scale testing (Phase 3)WithdrawnNCT02048111
What this trial is testing

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Cangene Corporation
Not applicableStudy completedNCT03430154
What this trial is testing

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

Who this might be right for
Haemophilia A, Haemophilia B, Obesity
Novo Nordisk A/S 317
Post-approval studies (Phase 4)WithdrawnNCT00168051
What this trial is testing

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableEnded earlyNCT02807753
What this trial is testing

The Hemophilia Ultrasound Project

Who this might be right for
Hemophilia AHemophilia B
University of Miami 18
Not applicableWithdrawnNCT04541875
What this trial is testing

Medication Adherence and Non-adherence in Adults With Rare Disease

Who this might be right for
Cystic FibrosisHemophilia AHemophilia B+3 more
Xperiome
Post-approval studies (Phase 4)Study completedNCT01561391
What this trial is testing

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 36
Testing effectiveness (Phase 2)Study completedNCT03588299
What this trial is testing

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"

Who this might be right for
Hemophilia A
Bayer 11
Not applicableStudy completedNCT01586936
What this trial is testing

Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 9
Not applicableUnknownNCT05439642
What this trial is testing

Validation and Reliability of the CHO-KLAT in Turkish

Who this might be right for
Hemophilia AHemophilia B
Yuzuncu Yil University 100
Testing effectiveness (Phase 2)Study completedNCT00245245
What this trial is testing

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

Who this might be right for
Hemophilia A
Octagen Corporation 12
Large-scale testing (Phase 3)Ended earlyNCT02895945
What this trial is testing

BAX 802 in CHA With Inhibitors

Who this might be right for
Hemophilia A
Baxalta now part of Shire 8
Not applicableStudy completedNCT02540187
What this trial is testing

Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients

Who this might be right for
Hemophilia
Centre Hospitalier Universitaire de Saint Etienne 164
Not applicableLooking for participantsNCT04817462
What this trial is testing

Liver Biopsy In Haemophilia Gene Therapy

Who this might be right for
Hemophilia B, SevereHemophilia A, Severe
University College, London 10
Not applicableStudy completedNCT01579968
What this trial is testing

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 86
Not applicableStudy completedNCT03660774
What this trial is testing

The Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

Who this might be right for
Haemophilia AHaemophilia B
Novo Nordisk A/S 563
Not applicableStudy completedNCT02740413
What this trial is testing

Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

Who this might be right for
Hemophilia AHemophilia B
Pfizer 86
Early research (Phase 1)Study completedNCT01233440
What this trial is testing

Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 25
Post-approval studies (Phase 4)UnknownNCT04108260
What this trial is testing

The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients

Who this might be right for
Hemophilia
National Taiwan University Hospital 5
Next Page